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A 1,3-DIPOLAR CYCLOADDITION APPROACH TO THE SYNTHESIS OF 
RESINIFERATOXIN 
Jennifer A. Loyer-Drew, M.S. 
University of Pittsburgh, 2008
 
The Rh(I)-catalyzed allenic cyclocarbonylation reaction is a formal [2 + 2 + 1] cycloaddition 
process that has been used to gain access to 4-alkylidenecyclopentenones.  Incorporation of a 
six-membered ring on the tether between the allene and the alkyne components allows access to 
a variety of [6-7-5] ring structures featured in the skeletons of various natural products, including 
resiniferatoxin.  This thesis describes the development of two systems, each with a future 
synthesis of resiniferatoxin in mind.  First, a model system was designed to demonstrate the 
compatibility of the isoxazoline moiety with the Rh(I)-catalyzed cyclocarbonylation reaction.  
The second investigation involved the synthesis of an asymmetrically functionalized 2-
cyclohexenone in order to attempt a stereoselective 1,3-dipolar cycloaddition.  The first model 
system successfully led to the synthesis of the unfunctionalized [6-7-5] core of resiniferatoxin 
via cyclocarbonylation of an isoxazoline-containing allene-yne.  Unfortunately, under numerous 
conditions, the functionalized cyclohexenone synthesized for the second study failed to undergo 
1,3-dipolar cycloaddition with a nitrile oxide. 
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ABBREVIATIONS 
Ac2O Acetic anhydride 
9-BBN 9-Borabicyclo[3.3.1]nonane 
BINOL 1,1’-Bi(2-naphthol) 
DCM Dichloromethane 
DIPA Diisopropylamine 
DMAP 4-N,N-Dimethylaminopyridine 
DMF N,N-Dimethylformamide 
DMSO Dimethylsulfoxide 
EtOAc Ethyl acetate 
NMR Nuclear magnetic resonance 
PAA para-Anisaldehyde 
PhH Benzene 
TBS tert-Butyldimethylsilyl 
TEA Triethylamine 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
TMEDA N,N,N’,N’-Tetramethylethylenediamine
TMS Trimethylsilyl 
1.0  INTRODUCTION 
1.1 RESINIFERATOXIN 
The therapeutic benefits of euphorbium—the dried latex of plants of the genus Euphorbia—have 
been appreciated for several centuries; in his posthumously published Tractatus de Materia 
Medica, 18th century French chemist and physician Etiénne-François Geoffroy cites euphorbium 
as an effective remedy for bone cavities and nerve pains.1 Although euphorbium disappeared 
from the documented pharmacopoeia in the 1800s, interest in its active constituent, 
resiniferatoxin (1, Figure 1), has been renewed, as resiniferatoxin shows potential in treating, 
among other ailments, chronic pain and bladder incontinence. 
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Figure 1. Structures of resiniferatoxin and capsaicin 
Resiniferatoxin was isolated in 1975 from the latex of Euphorbia resinifera and related 
plants by Hecker and colleagues.2 The high irritant activity of the compound was immediately 
recognized as novel and, seven years later, Hecker published a revised structure of the natural 
product along with the results of preliminary structure-activity studies.3 Although the 
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pharmacophore has not been determined, the phenol and orthoester moieties have been deemed 
essential for potency. 
Resiniferatoxin is a known agonist of the transient receptor potential vanilloid (TRPV1).  
Analogous physiological effects and structural similarities to capsaicin (2)—also an irritant that 
binds to a TRPV1—suggest a common mode of action for the two compounds.  Both natural 
products induce pain, neurogenic edema and hypothermia in rats.4 
Vanilloid receptors are ligand-gated cation channels located in the membranes of 
nociceptive sensory nerves.  Activation of the proteins by chemical agonists or heat causes the 
channel to open, leading to an influx of intracellular calcium cations; this depolarization 
generates an action potential that is perceived by the central nervous system and leads to a 
burning sensation.  In 1997, Julius and coworkers5 cloned TRPV1 and characterized the protein 
as containing six transmembrane domains.  The vanilloid binding pocket was later located 
through the use of radiolabeled resiniferatoxin, and was shown to exist between domains three 
and four.6 
Although capsaicin and resiniferatoxin cause initial irritation at the site of application, 
tachyphylaxis is demonstrated upon subsequent exposure.  This phenomenon is much more 
prominant with the use of resiniferatoxin than with capsaicin, although the initial irritation 
caused by resiniferatoxin is only marginally more severe.  The exact mechanism of 
desensitization remains elusive, but summaries of thoughtful speculation can be found in several 
reviews.7-9  
Not only are nociceptors exposed to resiniferatoxin densensitized to further treatment with 
resiniferatoxin, but they often show diminished responses to other stimuli as well, including 
capsaicin, heat and other exogenous inflammatory agents.  Thus, resiniferatoxin is viewed as a 
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potentially valuable analgesic for those suffering from chronic neurogenic pain and other 
phenomena that result from hyperactive nociceptors.  
In particular, some subjects exhibiting symptoms of overactive bladder and incontinence 
have been reported to have an abnormally high density of nociceptive neurons present in their 
bladder tissues.  Introduced intravesically, low concentration solutions of resiniferatoxin have 
been shown to lead to a decreased frequency in incontinent episodes in some of these patients; 
the effects of a single treatment can last up to three months and the initial discomfort is 
minimal.10, 11  
Current investigation of clinical applications of resiniferatoxin seems to be taking place 
predominantly in the academic arena.  This may be due, in part, to a 2004 press release issued by 
ICOS stating their findings that resiniferatoxin did not pass Phase II trials for treatment of 
interstitial cystitis12 and that ICOS’s interest in resiniferatoxin had ceased.13 Since this statement 
by ICOS, however, additional contradictory reports14 demonstrating the efficacy of 
resiniferatoxin in treating bladder pain syndrome and interstitial cystitis have appeared in the 
literature.  
Some scientists have expressed reservations with respect to treating humans with 
resiniferatoxin based on the similarities between its structure and those of the tumor-promoting 
phorbol esters (12,13-diesters of 3, R1 = OH, R2 = H, Figure 2);15 however, these concerns are 
not corroborated by experimental evidence.  Notably, prostratin (3, R1 = H, R2 = Ac, Figure 2), a 
12-deoxytigliane recently synthesized by Wender and coworkers16 from phorbol, was shown to 
be a non-tumor-promoting potential anti-HIV therapeutic.  Prostratin is currently in preclinical 
development. 
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Figure 2.  Phorbol and prostratin 
The FDA designated resiniferatoxin as an orphan drug in 2003 for the treatment of 
“intractable pain at end-stage disease.”17 This classification seems especially befitting in light of 
a 2005 publication from the School of Veterinary Medicine at the University of Pennsylvania.  
Administered intrathecally, resiniferatoxin appeared to largely diminish the pain associated with 
bone cancer as experienced by a group of canine companion animals.18 When the dogs entered 
the study, many were not deemed to be achieving adequate pain relief through the use of 
conventional analgesics.  After treatment with resiniferatoxin, the comfort level of most of the 
dogs seemed to improve so drastically that analgesic use was tapered or in some cases 
discontinued completely.  No lasting ill effects of resiniferatoxin were observed, pre- or 
postmortem.   
TRPV1 has become a popular target for development of analgesics; a number of TRPV1 
antagonists are in clinical development to address painful phenomena ranging from migraine 
headaches to HIV neuropathy-associated pain.19, 20 Capsaicin is available over-the-counter as a 
topical ointment for the treatment of arthritis pain.  Recent publications regarding the therapeutic 
possibilities of resiniferatoxin include a study of its use as a long-lasting local anasthetic21 and a 
patent application alleging the efficacy of injections of resiniferatoxin in treating joint pain.22 
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The isolation of resiniferatoxin from euphorbium continues to be a materials-intensive 
and fairly noxious process.  Fattorusso23 has published an improved procedure for the isolation 
of resiniferatoxin, but only managed a 0.0020% yield from the fresh latex of the E. resinifera 
plant.  One of the altruistic goals of the synthesis of resiniferatoxin is to provide a vehicle for 
synthesis and testing of analogs that are more accessible or that perhaps possess more optimal 
biological activity than the natural product itself. 
1.2 STRUCTURALLY-RELATED NATURAL PRODUCTS 
While it is our objective to carry out a synthesis of resiniferatoxin, our expectation is that the 
methods that we utilize will find application in the synthesis of structurally-similar molecules.  
Many daphnane diterpenoids have been isolated from natural sources; they collectively exhibit a 
wide variety of fascinating and potentially useful biological activities.24 Several of these natural 
products are depicted in Figure 3 with their corresponding biological activities.25-31 Phorbol (3, 
R1 = OH, R2 = H, Figure 2), a tigliane diterpene, is also notable not only for the biological 
activity of its 12,13-diesters, but also for the inspirational amount of creative chemistry that has 
been developed in pursuit of its synthesis. 
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Figure 3. Daphnane natural products 
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2.0  PREVIOUS APPROACHES TO THE SYNTHESIS OF RESINIFERATOXIN AND 
RELATED COMPOUNDS 
To date, there has been only one total synthesis of resiniferatoxin, published by Wender in 
1997.32 The absolute stereochemistry was set in the first step: known epoxide 4 (Scheme 1) was 
synthesized from 1,4-pentadien-3-ol using Sharpless’ asymmetric epoxidation conditions.  
Subsequent steps proceeded stereoselectively, affording intermediate 5. The key step in 
Wender’s synthesis was a [5 + 2] intramolecular cycloaddition of oxidopyrylium 6, forming the 
B and C rings simultaneously.  An advantage of this tactic was the resulting rigidity of the 
tricyclic ring system.  The presence of the bridging ether in 7 lent bias to the formation of 
subsequent stereocenters.  A zirconium-mediated cyclization of enyne 8 closed the A ring of 
resiniferatoxin and further elaboration of 9 led to completion of the natural product.  
Esterification at C20 and construction of the orthoester were performed towards the end of the 
synthesis, since these moieties have been shown to be essential for potent irritant activity. 
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Scheme 1. Wender's synthesis of resiniferatoxin 
Carreira’s group33, 34 has published two papers disseminating complementary approaches 
to the construction of angular [6-7-5] ring structures.  Substrates and conditions for 
diastereoselective phenol para-alkylation were developed in order to gain access to spiro-fused 
cyclohexadienones (Scheme 2).34 Conversion of optically pure alcohol 10 to the 3,5-
bistrifluoromethylbenzenesulfonate ester and subsequent Winstein alkylation provided 
cyclohexadienone 11 as a single stereoisomer in 95% yield.  Previously, Carreira and 
colleagues33 had shown that tricyclic compound 12 could undergo photorearrangement via 
intermediate 13 to directly provide the [6-7-5] core 14 of resiniferatoxin and similar natural 
products (Scheme 3).  Enone 14 was elaborated further to give the highly oxygenated ketal 14 in 
order to demonstrate the synthetic potential of the photorearrangement approach. 
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Scheme 3. Carreira's approach to resiniferatoxin 
The Wender group has applied their [5 + 2] cycloaddition chemistry several times to the 
synthesis of phorbol; their most recent synthesis was asymmetric.35-38 Wender39 recently 
published preliminary results on the application of this methodology towards the synthesis of 
gnidimacrin.  
The only other complete synthesis of phorbol to date was published by Lee and Cha40 in 
2001.  Like Wender, Lee and Cha employed a cycloaddition as a key step.  [4 + 3] Cycloaddition 
of furan 16 (Scheme 4) and the oxyallyl generated from 1,1,3-trichloroacetone (17), followed by 
dechlorination with zinc, afforded meso compound 18 (R = TBS).  Desymmeterization of the 
corresponding acetate (18, R = Ac) was performed enzymatically to give alcohol 19 in 90% yield 
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and 80% ee.  Subsequent steps proceeded diastereoselectively to give substrate 20 which 
underwent an intramolecular Heck reaction to close the C ring.  Lee and Cha later intersected 
with Wender’s synthesis of phorbol. 
There have been numerous innovative approaches to the construction of a suitably 
functionalized angular [6-7-5] tricyclic core of phorbol; these strategies include: Diels–Alder 
cyclization,41-43 an intramolecular 1,3-dipolar cycloaddition,44, 45 a diyl-trapping cycloaddition,46 
and an anionic oxy-Cope rearrangement.47 The obvious challenges of constructing the polycyclic 
core of resiniferatoxin and related natural products that possess opportunely located functionality 
have inspired many chemists in the synthetic community, including the Brummond group. 
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Scheme 4. Cha's synthesis of phorbol 
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3.0  RETROSYNTHETIC ANALYSIS OF RESINIFERATOXIN 
3.1 ACCESSING THE A AND B RINGS VIA A Rh(I)-CATALYZED ALLENIC 
CYCLOCARBONYLATION REACTION 
The Brummond group has been preeminent in applying transition metal catalysis to the creation 
of a diverse array of polycyclic scaffolds via the Pauson–Khand-type cyclocarbonylation of 
allenes.48-55 Former group members have demonstrated the utility of the molybdenum-mediated 
and rhodium-catalyzed methodologies in their application to natural product synthesis.48, 50-52 A 
unique feature of the rhodium-catalyzed system is its selectivity for reaction with the distal 
double bond of the allene;49 in this way, our group has been able to selectively access a variety of 
4-alkylidene cyclopentenones by varying the length of the tether between the allene and alkyne 
moieties (Scheme 5).   
•
O
[Rh(CO)2Cl]2, CO
 
Scheme 5. Cyclocarbonylation of a tethered allene-yne 
Incorporation of a six-membered ring on the tether between the allene and alkyne has 
allowed access to a variety of angular and linear [6-7-5] tricyclic skeletons present in several 
natural products (Scheme 6).48, 50 The angular [6-7-5] substructure present in resiniferatoxin 
seems specially suited to showcase our group’s cyclocarbonylation methodology.48 The 
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unsaturation present in the cyclocarbonylation product is conveniently situated at sites requiring 
oxidation.  Further, the rhodium-catalyzed reaction has demonstrated excellent functional group 
compatibility.  In the case of resiniferatoxin, this tolerance would permit us to submit an allene-
yne tethered by a functionalized C ring to the cyclocarbonylation reaction, yielding an advanced 
synthetic intermediate. 
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Scheme 6.  Access of [6-7-5] skeletons via allenic cyclocarbonylation reaction 
We envision a formal synthesis of resiniferatoxin, intersecting Wender’s total synthesis at 
intermediate alcohol 21 (Scheme 7).  We intend to gain access to this intermediate via functional 
group manipulation of 22.  A key premise of our proposal is the use of the isoxazoline moiety as 
a masked aldol equivalent (see section 3.2); thus, opening of the isoxazoline ring in 23 will yield 
β-hydroxy ketone 22.  Isoxazoline 23 may be obtained by performing selective oxidations and 
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olefination of 24, the cyclocarbonylation product of allenyne 25.  Conversion of the ketone 
present in 26 to the allene, followed by deprotection of the TBS ether, oxidation to the aldehyde, 
and propargylation will yield allene-yne 25.  We propose that a regio- and stereospecific 1,3-
dipolar cycloaddition of enone 28 and nitrile oxide 27 will provide access to isoxazoline 26. 
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Scheme 7. Retrosynthetic analysis of resiniferatoxin 
3.2 THE MASKED ALDOL STRATEGY: 1,3-DIPOLAR CYCLOADDITION TO 
FORM AN ISOXAZOLINE 
1,3-Dipolar cycloaddition of nitrile oxides to provide isoxazolines followed by reduction of the 
N-O bond and hydrolysis of the resulting imine is a strategy for accessing β-hydroxy ketones.56 
While numerous synthetic innovations allow for control of aldol product stereochemistry and 
preferential formation of a singular cross-aldol product, the cycloaddition of nitrile oxides and 
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olefins continues to offer an elegant alternative to the aldol reaction.57-61 The characteristics that 
attracted us to the nitrile oxide cycloaddition approach were:  
(1) The potential for selectively establishing two stereocenters and latent 
functionality in a single step;  
(2) The ability of the isoxazoline to act as a protecting group for functionality to be 
unmasked late in the synthesis; and 
(3) Rigidification of the cyclocarbonylation product to provide a clear facial 
preference for subsequent oxidations. 
We anticipate that the regioselectivity of the cycloaddition will be influenced by the 
presence of the enone.  High regioselectivity has been reported for the reaction of nitrile oxides 
with cycloalkenones, largely due to steric effects.62 We anticipate that the hydroxyl group may 
aid in guiding the nitrile oxide to a syn approach, as well as in reinforcing the regioselectivity; 
although, this type of assistance is not well supported in the literature.  While hydrogen-bonding 
has not been observed to be a strong enough force to consistently direct the 1,3-dipolar 
cycloaddition of nitrile oxides,63-65 supplanting the proton of the alcohol with a stronger Lewis 
acid has been demonstrated to lead to high regio- and stereoselectivity.66-70   
Kanemasa and colleagues70 found that conversion of allylic alcohols to the corresponding 
magnesium alkoxide (e.g., 30, X = MgBr, Table 1) and subsequent exposure to benzonitrile 
oxide (generated through dehydrohalogenation of hydroximoyl chloride 29) gave the 
corresponding isoxazolines in a highly regio- and stereoselective fashion (Table 1, entry 2).  It 
was noted, however, that the reaction of the magnesium alkoxide generated from 2-cyclohexenol 
“led to the formation of a complex mixture of many products.”  
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Table 1.  Magnesium alkoxide direction in 1,3-dipolar cycloaddition (Kanemasa) 
N
OH
ClPh
base
OX
Ph
N O
OH
Ph
N O
OH
Ph
N O
OH
+ +
31                            32                             3329
30
 
Base X Yield (%) 31 : 32 : 33
TEA H 28 55 : 27 : 18
EtMgBr MgBr 53 94 : 6 : 0 
A related result was realized in a study of the directing abilities of 2° amides conducted 
by a member of the Curran group.  After exposure to conditions that led to satisfactory formation 
of the syn-cycloadduct 36 of the corresponding cyclopentenyl amide (35, n = 0, Table 2, entry 1), 
unreacted cyclohexenyl amide (35, n = 1) was recovered, even when the reaction was heated to 
80 °C for nearly 10 days (Table 2, entries 2 and 3).68 Choi suggested this result was due to the 
relatively low reactivity of cyclohexene-derived substrates towards cycloaddition and to the 
inability of such substrates to adopt the necessary hydrogen-bonded transition state. 
Table 2. Hydrogen bond direction in 1,3-dipolar cycloaddition (Choi) 
N Ph
O
H
TEA N Ph
O
H
O
N
t-Bu
+N
OH
Clt-Bu
N Ph
O
H
O
N
t-Bu
N Ph
O
H
N
O
t-Bu
+ +
34 35 36 37 38
(  )n (  )n (  )n (  )n
 
Entry n Time (days) T (°C) Yield (%) 36 : 37 : 38 
1 0 4.5 25 92 85 : 1 : 14 
2 1 4.5 25 NR NA 
3 1 9.5 80 NR NA 
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It is possible that the facial selectivity of the 1,3-dipolar cycloaddition will be controlled 
by sterics alone.  In studies directed toward the synthesis of breynolide, the Martin group71, 72 
observed a single cycloadduct 41 resulting from addition of the nitrile oxide generated from 
hydroximoyl chloride 40 anti to a large substituent on a cyclohexenone substrate 39 (Scheme 8). 
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37%
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Scheme 8. Steric direction of nitrile oxide cycloaddition (Martin) 
The presence of the isoxazoline ring will impose considerable conformational constraints 
on our synthetic intermediates.  Molecular modeling of the two possible diastereomers (resulting 
from the propargylation step) of the cyclocarbonylation product using Spartan shows that each 
molecule possesses a convex and a concave face (Figure 4).  In both cases, the more sterically 
accessible convex face is the face on which we hope to perform selective oxidations of the 
enone. 
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Figure 4. Molecular modeling of cyclocarbonylation products 
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4.0  RESULTS AND DISCUSSION 
4.1 INTRODUCTION 
Prior to committing to the synthesis of resiniferatoxin, our retrosynthetic plan required that we 
address three questions:  
(1) Is the isoxazoline moiety tolerated by the reaction conditions we wish to 
employ, namely the Rh(I)-catalyzed cyclocarbonylation protocol? 
(2) Is selective oxidation of the resulting alkylidene cyclopentenone feasible? 
(3) Are we able to carry out a stereoselective [3 + 2] cycloaddition? 
In order to satisfy these queries, we embarked on two separate investigations.  We utilized a 
model system to demonstrate the compatibility of the isoxazoline moiety with the rhodium-
catalyzed cyclocarbonylation reaction (section 4.2).  Also, this model system will allow us to 
ascertain the utility of the cyclocarbonylation product in subsequent selective oxidation. 
Concurrently, an asymmetrically functionalized C ring was prepared to probe the possibility of 
obtaining selectivity in the 1,3-dipolar cycloaddition (section 4.3). 
 18 
4.2 MODEL SYSTEM CONTAINING AN UNFUNCTIONALIZED C RING 
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N
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N
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2-cyclohexenone (44)
43%
84% 74% 87%
89% 75%
42
 
Scheme 9.  Synthesis of model system 
Under my direction, undergraduate researcher Darla Seifried explored the steps shown in 
Scheme 9.73 I have since repeated the reactions several times to investigate the propargylation 
and subsequent cyclocarbonylation steps.  All yields reported are from my syntheses.  
Nitroethanol (42) was protected as the TBS ether 43, which then underwent in situ dehydration 
and 1,3-dipolar cycloaddition with 2-cyclohexenone (44) to give bicycle 45 as a single 
regioisomer.  Initially, phenylisocyanate was used as the dehydrating agent;74 however, the 
diphenyl urea byproduct generated during the reaction was extremely difficult to remove from 
the desired product via either multiple precipitations (using ethyl acetate, hexanes, ether, or 
water) of the urea or column chromatography.73 Kurth and colleagues75 have reported a clever 
solution to this frequently observed problem: the use of 1,4-phenylene diisocyanate generates a 
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polyurea that is insoluble in organic solvents (THF, methylene chloride and benzene) and can 
therefore be removed by filtration.  We found Kurth’s method to be satisfactory, although a 
single filtration is rarely sufficient to remove the significant quantities of polymeric urea present 
in the reaction mixture. 
The regioselectivity of the cycloaddition was confirmed by 1H NMR.  In isoxazoline 45, 
H5 gives a doublet of triplets resonance at δ 4.95 ppm and H4 appears as a doublet at δ 3.86 ppm 
(Figure 5).  This is consistent with the findings of Grünanger and colleagues62 in their studies of 
the relationship between regioisomers and chemical shift in similar systems.  In the addition of 
benzonitrile oxide to 2-cyclohexenone (44), the multiplet resonance for H5 appears significantly 
downfield from the H4 doublet in the major product 51 (Scheme 10).  The ΔδH4,H5 is much 
smaller for the regioisomer 52, and the more deshielded proton—H5—is alpha to the ketone and 
therefore only split by H4 (i.e., appears as a doublet).  Grünanger observed only cis-addition to 
cycloalkenones, the products exhibiting a characteristically large 3JH4,H5 (8.8 to 12.0 Hz).  The 3J 
coupling (9.7 Hz) exhibited by H4 and H5 in isoxazoline 45 falls neatly within this range.76, 77  
4
5 N
O
Ph
H
H
O
O
Ph
N
OH
Cl
TEA
Et2O, rt, 12 h
85%
3 : 1 (51 : 52)
+ +
2944 51
H4: δ 4.23 (d)
H5: δ 5.12 (m)
52
H4: δ 4.20 (m)
H5: δ 4.68 (d)
4
5 N
O
Ph
H
H
O
 
Scheme 10.  Dependence of chemical shift on regioselectivity in nitrile oxide cycloaddition (Grünanger)  
 20 
 4
5 N
O
H
H
O
45
OTBS
 
 
H4
H5 
Figure 5.  1H NMR verification of regioselectivity 
Addition of ethynylmagnesium bromide to the ketone 45, followed by acylation of the 
tertiary alcohol 46, gave propargyl acetate 47 as a single diastereomer.  As has been experienced 
by other group members,48, 51 Stryker’s reagent ([(Ph3P)CuH]6) was suitable for the reduction of 
the propargyl acetate 47 to the corresponding 1,1-disubstituted allene 48.  Initial yields obtained 
for the reduction of the propargyl acetate 47 using commercial samples of Stryker’s reagent were 
around 45%.  Others78-80 have remarked on the variable (and generally inferior) quality of 
commercial [(Ph3P)CuH]681 as compared to Stryker’s reagent that has been prepared in the 
laboratory.  Consequently, the copper hydride species was prepared according to the literature82 
and, using the fresh reagent, the yield of allene 48 nearly doubled to 87%.  Deprotection of the 
TBS ether 48 followed by Swern oxidation83 of the primary alcohol 49 gave aldehyde 50. 
 21 
The addition of nucleophiles to 3-formyl-Δ2-isoxazolines is precedented,84 although 
propargylation has not been reported.  A zinc Barbier reaction of the aldehyde 50 and propargyl 
bromide in aqueous ammonium chloride produced the desired homopropargyl alcohol 53 in 
variable yield as a 3:1 mixture of diastereomers (Scheme 11).  However, subjecting this substrate 
to the [Rh(CO)2Cl]2 cyclocarbonylation conditions led mostly to decomposition.  Other group 
members have observed similar behavior in the case of terminal alkynes.48 Attempts at protecting 
the terminal alkyne 53 with a trimethylsilyl group proved unsuccessful and efforts to force the 
formation of 54 by exposure of the protected alcohol to excess base led primarily to 
decomposition. 
N
O
O•
Br
Zn, sat NH4Cl, THF
N
O
OH•
54-70%
53
3:1 dr
N
O
OR•
TMS5450
 
Scheme 11. Propargylation of aldehyde 50 
In reexamining the propargylation step, it seemed necessary to install the propargyl group 
and to protect the terminal alkyne in a single step.  There are relatively few methods of 
accomplishing this.  Most propargylation conditions rely upon the favorable equilibrium of the 
propargylic and allenic organometallic species, 56 and 57, respectively (Scheme 12), the latter 
leading to the α-addition product 58 via an SE2’ mechanism.85 Sterically demanding groups on 
the terminus of the alkyne (e.g., R1 = TMS) may shift this equilibrium to favor the propargyl 
organometallic species 56, giving the allenic alcohol 55 preferentially.  The product distribution 
has, however, been found to be highly dependent on the metal used, the nature of the substituent 
on the alkyne (R1), the electrophile, and reaction solvent.  
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Scheme 12. Regioselectivity in propargylation reactions 
Paquette and Daniels86 have published an often-cited study that exemplifies the 
capricious behavior of propargylation reactions.  Treatment of aldehydes and ketones with 
trimethylsilylpropargylzinc bromide in THF led to selective formation of the homopropargylic 
alcohol, while treatment of the same substrates with the analogous aluminum reagent yielded 
allenyl alcohols preferentially.  Additionally, increasing the coordinating ability of the solvent 
was highly influential in the product distribution of protonolysis of the aluminum reagent; in 
diethyl ether, 1-trimethylsilylpropyne was obtained after quenching the organometallic species, 
while in THF or diglyme the regioselectivity was reversed.   
Unfortunately, Paquette and Daniels’87 zinc amalgam protocol failed to produce the 
desired homopropargyl alcohol 54 (Table 3, entry 1).  The majority of the starting material 50 
was recovered.  Propargylation of aldehyde 50 was attempted using conditions developed by Loh 
and Lin,88 who have shown that simple aldehydes undergo regioselective propargylation with 
trialkylsilyl propargyl bromides in the presence of indium and catalytic indium trifluoride.  Lin 
and Loh attribute the high selectivity for the α-alkylation product to the probable coordination of 
the halogen and the silicon in the allenic organometallic species 57.  This protocol proved 
ineffective in the propargylation of our aldehyde 50, however (entry 2).  The majority of the 
starting material was recovered. 
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Table 3. Propargylation of aldehyde 50 
N
O
O•
Br
conditions
N
O
OR2•
5450
TMS
R1
 
Entry R1 Conditions R2 Yield of 54 (%)
1 TMS Zn, HgCl2, cat I2 NA NR 
2 TMS In, InF3, THF, reflux NA NR 
3 H 2 equiv n-BuLi, TMEDA, then TMSCl TMS 21 (2:1 dr) 
Cabezas89, 90 has also presented an approach to the problem of regioselective addition, in 
which 1,3-dilithiopropyne is prepared from propargyl bromide and added to the aldehyde.  
Quenching of the reaction with TMSCl protects both the newly formed alcohol and the alkyne 
terminus.  Employment of this method gave the desired bis-protected homopropargyl alcohol 54 
(R2 = TMS), albeit in 21% yield as a 2:1 mixture of diastereomers by 1H NMR (Table 3, entry 
3).   
Gratifyingly, when subjected to [Rh(CO)2Cl]2 in the presence of CO, allene-yne 54 
smoothly underwent cyclocarbonylation to give the desired product 59 in 91% yield after 3 hours 
(Scheme 13).  Following cyclocarbonylation, the two diastereomers (originating in the 
propargylation step) were easily separated by column chromatography, yielding 10 mg (73%) of 
the major diastereomer, and 3 mg (18%) of the minor isomer.  
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Scheme 13. Cyclocarbonylation of the model system 
There is a minor discrepancy between the isolated yields of the diastereomers of 59 and 
the previously observed 2:1 dr observed in the 1H NMR of the homopropargyl silyl ether 54.  
Were the remaining 9% of the material not isolated as product comprised solely of the minor 
diastereomer of 54, the diastereomeric ratio observed in the cyclocarbonylation reaction 
(potentially 73:27) still would not be equivalent to 2:1.  This lack of agreement may be attributed 
to two things.  First, the 2:1 dr is based on the integration of methine protons that are not fully 
resolved in the 1H NMR spectrum (see Appendix A).  Second, the margin of error in weighing 
milligram quantities is presumably large enough to account for the observed discrepancy.   
In an effort to gain insight into the relative stereochemistry of the cyclocarbonylation 
products, the two epimers of 59 were modeled using CAChe.  The global minimum 
conformation for each isomer was found using CONFLEX/MM3 parameters (Figure 6).91 The 
minimum energy conformer for the epimer with the α-TMS ether (59α) exhibited dihedral 
angles of 70.2 and 44.3° between Ha and Hb, and Ha and Hc, respectively.  The measured dihedral 
angles for 59β are 176.2 and 60.9°.  Based on these calculations, one would expect to observe a 
doublet of doublets with two medium-to-small 3J couplings for the resonance of Ha in 59α.  In 
contrast, the calculated dihedral angles for 59β predict a doublet of doublets with one large and 
one small vicinal coupling.  Indeed, the resonance for Ha in the 1H NMR spectrum of the major 
diastereomer of 59 is a triplet at δ 5.01 ppm with J = 3.6 Hz (see Appendix A).  The 
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corresponding signal in the 1H NMR spectrum of the minor diastereomer is a doublet of doublets 
at δ 4.76 ppm with J = 10.8 and 5.4 Hz.  Therefore, the major and minor diastereomers can 
tentatively be assigned as 59α and 59β, respectively. 
 
O
N
O
TMS
59α
OTMS
Ha
Hc
Hb O
N
O
TMS
59β
Ha
OTMS
Hc
Hb
Ha-C-C-Hb ∠ 70.2°
Ha-C-C-Hc ∠ 44.3°
observed for Ha: δ 5.01 (t, J = 3.6 Hz)
Ha-C-C-Hb ∠ 176.2°
Ha-C-C-Hc ∠ 60.9°
observed for Ha: δ 4.75 (dd, J = 10.8, 5.4 Hz)  
Figure 6.  Minimum energy conformations and dihedral angles for 59α (left) and 59β (right) 
4.3 SYNTHESIS OF AN ASYMMETRICALLY-FUNCTIONALIZED C RING 
Our strategy for the synthesis of a functionalized C ring was to add isopropenyl Grignard to 
known enone 60 (Scheme 14), hydrate the exocyclic olefin of 62 and cleave the ketal to access 
functionalized enone 28.   
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Scheme 14. Proposed synthesis of functionalized C ring 
4.3.1 Conjugate addition to cyclohexadienone 62 to form enone 60 
There are only a few literature examples of conjugate addition of a methyl group to quinone 
monoketal 62.  Addition of lithium dimethylcopper to quinone monoketal 6292 is known to lead 
to reductive aromatization rather than conjugate addition (Table 4, entry 1).93 Complexation of 
quinone monoketals with an organoaluminum reagent followed by addition of either an 
alkyllithium or Grignard reagent has been shown to yield the corresponding 1,4-addition 
products in many cases; however, in the case of the addition of methyllithium, only a 24% yield 
of the desired product 60 was achieved (entry 2).94 Fortunately, Feringa and colleagues95 have 
developed an enantioselective copper-catalyzed conjugate addition protocol that was reported to 
give the desired enone 60 in 76% yield and 99% ee from quinone monoketal 62 (entry 3). 
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Table 4. Literature examples of conjugate addition to quinone monoketal 62 
O
MeO OMe
62
conditions
O
MeO OMe
60  
Entry Conditions Yield (%) Ref. 
1 LiMe2Cu —a 93 
2 MAD,b MeLi 24 94 
3 Cu(OTf)2, (S,R,R)-64, Me2Zn 76 (99% ee) 95 
ap-Methoxyphenol obtained exclusively; bMAD =  
methylaluminum bis(2,6)-di-tert-butyl-4-methylphenoxide) 
The enantioselectivity of Feringa’s protocol arises from the use of chiral phosphoramidite 
ligand 64 (Figure 7).  The Feringa group has published the use of a variety of phosphoramidite 
ligands synthesized from BINOL, PCl3, and 2° amines.96 Because the price of the amines varies 
widely, we sought to synthesize an effective phosphoramidite ligand while minimizing cost.  We 
were encouraged to see that both ligand (S)-63 and (S,R,R)-64 were effective in the copper-
catalyzed addition of diethylzinc to 2-cyclohexenone, each giving 3-ethylcyclohexanone in 
>75% yield and 83% ee and >98% ee, respectively.96 Initially less concerned with the 
enantiopurity of the enone than with obtaining the desired material, we opted to synthesize 
racemic phosphoramidite 63 from racemic BINOL (rac-65), PCl3, and diisopropylamine 
(Scheme 15).   
O
P
O
N
O
P
O
N
Ph
Ph
(S,R,R)-64(S)-63  
Figure 7. Chiral phosphoramidite ligands 
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Scheme 15. Synthesis of racemic phosphoramidite ligand 63 
Unfortunately, exposure of quinone monoketal 62 to Cu(OTf)2, ligand rac-63, and Me2Zn 
in toluene at –25 °C failed to produce the desired product 60 in a reasonable yield (Table 5, 
entries 1 and 2).  The reaction did not go to completion, even when the mixture was allowed to 
stir at -25 °C for several days.  The lack of desired reactivity may have been due, at least in part, 
to the poor solubility of the catalyst complex in toluene at the reaction temperature.  Upon 
cooling the premixed solution of Cu(OTf)2 and ligand from room temperature to -25 °C, 
significant precipitation was observed. 
Enantiomerically pure phosphoramidite (S,R,R)-64 was synthesized in 26% yield in a 
fashion analogous to the previous phosphoramidite synthesis.96 Cu(OTf)2 was premixed with the 
phosphoramidite ligand and was then cooled to -25 °C; the quinone monoketal was added 
followed by a solution of Me2Zn.  Within approximately six hours, all cyclohexadienone 62 
starting material was consumed (this is in contrast to the 16 hours the reaction is reputed95 to 
require).  Surprisingly, a significant amount of the diaddition product 67 was observed in the 
product mixture (Table 5, entry 3).  Protonation of the Zn-enolate intermediate prior to 
quenching of the catalyst is requisite in order for a second 1,4-addition to occur.  TLC indicated 
a dramatic difference in the relative amounts of mono- and diaddition products (60 and 67, 
respectively) before and after quenching. The final ratio of mono- to diaddition products has 
been found to be somewhat contingent on the method of quenching.  This trend is summarized in 
Table 5 (entries 3-5), although it is important to note that exact ratios were not reproducible.  
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Following the published procedure,95 the addition of saturated aqueous NH4Cl to the reaction 
mixture led to greater relative amounts of the diaddition product 67 in the crude 1H NMR than 
did a basic quench (entries 3 and 4), which was prescribed by Rosalinde Imbos in her Ph.D. 
thesis.97 The ratio of mono- to diaddition product (60 : 67) was further improved by performing a 
reverse basic quench (entry 5).   
Table 5. Product distribution in copper-catalyzed conjugate addition to cyclohexadienone 62 
O
MeO OMe
2.5 mol% Cu(OTf)2
5 mol% ligand
toluene, -25 °C
62
O
MeO OMe
60
O
MeO OMe
67
*
+ + unreacted62
 
Entry Ligand Equiv Me2Zn 
Time 
(h) Quench 60 : 67 : 62
a Yield of 60 (%) 
1 rac-63 1.6 16 direct, sat NH4Cl — 17 
2 rac-63 1.6 + 1b 48 direct, sat NH4Cl — 20 
3 (S,R,R)-64 1.6 6 direct, sat NH4Cl 18 : 82 : 0 —c 
4 (S,R,R)-64 1.6 16 direct, 1 M NaOH 60 : 40 : 0 33 
5 (S,R,R)-64 1.6 6 reverse, 1 M NaOH 71 : 29 : 0 —c 
6 (S,R,R)-64 1.6 4d reverse, 1.5 M NaOH 75 : 0 : 25 50 
7 (S,R,R)-64e 1.6 16 direct, 1 M NaOH 100 : 0 : 0 21f 
adetermined by integration of crude 1H NMR; badditional equivalent Me2Zn added after 45 h; cyield not determined; 
dreaction followed closely by TLC and quenched at first faint sign of diaddition product; eligand of high purity; flow 
yield due to volatility of product 
The presence of the diaddition product proved to be problematic since separation of the 
mono- and diaddition products by column chromatography was not possible.  Two methods of 
minimizing the formation of the diaddition product were discovered.  The first was to monitor 
the reaction closely and quench the reaction as soon as there was TLC evidence of diaddition 
product forming (Table 5, entry 6).  An early quench of the reaction allowed for the isolation of 
an easily separable 3:1 mixture (by 1H NMR) of desired product 60 to unreacted starting 
 30 
material.  (Fortuitously, ketone 67 stains very darkly with PAA and although the diaddition 
product was evident by TLC, it often was only faintly—if at all—visible in the crude 1H NMR.) 
The use of phosphoramidite ligand of a higher purity also suppressed the formation of the 
unwanted diaddition product.98 Unsatisfied with the previously low-yielding synthesis of 
phosphoramidite 64, we developed a revised synthesis based on methods reported in Ate 
Duursma’s Ph.D. thesis.99 (S)-BINOL (65) was refluxed in PCl3 (Scheme 16).  Removal of the 
excess PCl3 under vacuum furnished phosphochloridite 66, which was dissolved in toluene and 
added to a solution of deprotonated amine (R,R)-68.  Not only did this method drastically 
improve the isolated yield of the ligand 64 (77% versus 26%), but also the ligand was 
significantly more pure by 1H NMR.100 Use of this ligand in the copper-catalyzed conjugate 
addition led only to the desired monoaddition product (Table 5, entry 7).  Unfortunately, 
repetition of the improved ligand synthesis procedure led to ligand of inferior purity that, in turn, 
led to significant quantities of diaddition product 67 produced in the copper-catalyzed 1,4-
addition reaction. 
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Scheme 16.  Improved synthesis of phosphoramidite (S,R,R)-64 
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4.3.2 Elaboration of enone 60 
Isopropenylmagnesium bromide was added to the ketone 60, affording the tertiary alcohol 61 in 
74% yield (Scheme 17).  Hydroboration of the 1,1-disubstituted olefin with BH3·DMS followed 
by oxidation101 gave the corresponding primary alcohol as a mixture of diastereomers.  Attempts 
to improve the diastereoselectivity by using bulky 9-BBN led to no appreciable hydroboration, as 
observed by the 1H NMR spectra of aliquots of the reaction mixture.  The mixture of 
diastereomers was taken on crude due to the lability of the ketal on silica gel, even when the 
column was pretreated with TEA.  The primary alcohol was protected as the TBS ether102 prior 
to cleavage of the ketal by Montmorillonite K10 clay,103 giving the enone 28 in 21% yield from 
61 as a 2:1 mixture of diastereomers by 1H NMR.   
O
MeO OMe
60
*
MgBr
THF
MeO OMe
61
OH 1. BH3·DMS, then
    H2O, NaOH, H2O2
28
OH
2. TBSCl, DMAP, TEA
3. Montmorillonite-K10
TBSO
O21%, 3 steps
74%
 
Scheme 17.  Synthesis of enone 28 
A variety of 1,3-dipolar cycloaddition conditions were surveyed, all of which were 
designed to generate the nitrile oxide very gradually to minimize homodimerization of the nitrile 
oxide.56 Unfortunately, enone 28 failed to undergo 1,3-dipolar cycloaddition and, in all cases, 
most of the starting material was recovered (Table 6).  A very small amount of a mixture of 
unknown products was isolated from the reaction of enone 28 with nitroalkane 43 when Kurth’s 
diisocyanate methodology75 was used (entry 6).  Since selectivity was not exhibited, 
investigation was discontinued. 
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 Table 6. Attempted stereoselective cycloaddition of enone 26 
OH
TBSO
O
OH
TBSO
O
N
O
R
28 26
Ph Cl
N
OH
NO2
TBSO
29 43
or
conditions
 
Entry 29 or 43 Conditions Scale  
(mg of 28) 
Yield of 26 (%)
1 29 EtMgBr, DCM70 10 — 
2 29 TEA, Et2O71 10 — 
3 29 KHCO3, DME104 10 — 
4 29 KHCO3, DME, Δ 10 — 
5 29 4 Å mol sieves, DCM105 21 — 
6 43 1,4-phenylene diisocyanate, TEA, PhH, reflux75 21 —a 
aMost of starting material was unreacted; however, a small amount of a mixture of unknown products was obtained. 
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5.0  CONCLUSION 
Our proposed plan for the synthesis of resiniferatoxin required that we addressed several 
uncertainties, namely whether an isoxazoline moiety would be tolerated by the Rh(I)-catalyzed 
cyclocarbonylation reaction, whether selective oxidations of the resulting alkylidene 
cyclopentenone could be carried out, and whether a stereoselective 1,3-dipolar cycloaddition was 
feasible.  We synthesized a simple isoxazoline-containing model system, which underwent 
Rh(I)-catalyzed allenic cyclocarbonylation to give the unfunctionalized angular [6-7-5] core of 
resiniferatoxin in 91% yield.  The cyclopentenone scaffold produced by the cyclocarbonylation 
reaction was an appropriate substrate for probing conditions for selective olefin oxidation, 
although selective oxidation was not pursued due to the disappointing results obtained in the area 
of stereoselective 1,3-dipolar cycloaddition.  An asymmetrically functionalized enone, 
corresponding to the C ring of resiniferatoxin, was synthesized utilizing Feringa’s Cu-catalyzed 
asymmetric conjugate addition protocol.  Unfortunately, the functionalized 2-cyclohexenone 
failed to undergo stereoselective 1,3-dipolar cycloaddition under numerous conditions tested.   
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6.0  EXPERIMENTAL 
6.1 GENERAL 
Unless otherwise specified, all nonaqueous reactions were performed in flame- or oven-dried 
glassware under N2 atmosphere using the appropriate syringe, cannula, and septum techniques.  
All solvents and reagents were purchased commercially and used as received unless otherwise 
noted.  Toluene, acetonitrile (MeCN), triethylamine (TEA), N,N,N’,N’-
tetramethylethylendiamine (TMEDA), and chlorotrimethylsilane (TMSCl) were distilled from 
CaH2 prior to use. Dimethyl sulfoxide (DMSO) was distilled from CaH2 and stored over 
activated 4 Å mol sieves. Tetrahydrofuran (THF) and diethyl ether (Et2O) were dried and 
deoxygenated by sequential passage through activated alumina and Q5 columns in a Sol-Tek ST-
002 solvent purification system; dichloromethane (DCM) was passed through an activated 
alumina column in the same system.  2-Cyclohexenone was distilled (47 °C at 9 mm Hg) and 
stored at -20 °C.  Acetic anhydride (Ac2O) was distilled (30 °C at 20 mm Hg) from P2O5 and 
stored in a desiccator.  Cu(OTf)2 and [(Ph3P)CuH]6 were stored in a glove box and dispensed 
using standard glove box techniques.  All solvents used in the preparation and reactions of air-
sensitive reagents were degassed by bubbling N2 for 20-30 min before use. 
Column chromatography was performed using silica gel (32-63 μm particle size, 60 Å 
pore size) purchased from Scientific Adsorbents, Inc. following the guidelines described in the 
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seminal publication on flash chromatography by Still and colleagues.106 Ethyl acetate (EtOAc) 
and hexanes used for chromatography were distilled prior to use.  TLC was performed using 
silica gel plates (60 F254, 250 μm thickness). 
1H and 13C NMR spectra were obtained on Varian 300 MHz instruments.  All chemical 
shifts (δ) are reported in ppm.  1H NMR spectra were calibrated to the residual CHCl3 peak at δ 
7.27; 13C NMR spectra were referenced to the CDCl3 resonance at δ 77.0.  The following 
abbreviations are used to denote the indicated splitting pattern 1H NMR spectra: s = singlet, d = 
doublet, t = triplet, q = quartet; abbreviations are used in combination to indicate more complex 
splitting (e.g., dtd = doublet of triplets of doublets).  Infrared spectra were obtained on a Nicolet 
Avatar E. S. P. 360 FT-IR. 
6.2 SYNTHESIS AND CHARACTERIZATION 
OTBS
O2N
43
OCN
NCO
TEA, PhH, reflux
O
N
O
OTBS
45
2-cyclohexenone (44)
 
3-((tert-Butyldimethylsilyloxy)methyl)-5,6,7,7a-tetrahydrobenzo[d]isoxazol-4(3aH)-one 
(45).  A mixture of cyclohexenone (44) (1.80 mL, 18.59 mmol, 1.0 equiv), nitroalkane 43 (3.75 
g, 18.28 mmol, 1.0 equiv), 1,4-phenylenediisocyanate (9.08 g, 56.69 mmol, 3.1 equiv) and TEA 
(0.50 mL, 3.59 mmol, 0.2 equiv) in benzene (180 mL) was refluxed.  After approximately 16 h, 
the turbid yellow mixture was cooled to rt; water (9 mL) was added and the mixture stirred 1 h.  
The polymeric urea was removed via vacuum filtration through a pad of celite; the filtrate was 
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dried (MgSO4) and concentrated under reduced pressure.  Benzene was added and the filtration 
step was repeated.  The filtrate was concentrated onto silica gel, which was dry-loaded onto a 
silica gel column for purification.  Gradient elution with EtOAc/hexanes (1:9 to 1:6) yielded 
isoxazoline 45 (2.212 g, 43%) as a colorless oil.  1H NMR (300 MHz, CDCl3): δ 4.95 (dt, J = 
9.7, 4.5 Hz, 1H), 4.56 (A of ABq, J = 12.5 Hz, 1H), 4.44 (B of ABq, J = 12.5 Hz, 1H), 3.86 (d, J 
= 9.7 Hz, 1H), 2.54-2.45 (m, 1H), 2.37-2.26 (m, 1H), 2.16-1.79 (m, 4H), 0.89 (s, 9H), 0.10 (s, 
3H), 0.09 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 205.3, 157.4, 81.5, 58.7, 58.5, 39.9, 26.4, 25.8, 
18.4, 18.3, -5.5, -5.6; IR (neat, NaCl): 2930, 2857, 1713, 1088, 837 cm-1; MS m/z (%): 283 (9), 
268 (73), 226 (90), 74 (100); EI-HRMS calcd for C14H25NO3Si [M]+ m/z: 283.1604, found: 
283.1610. 
N
O
OTBS
46
THF, 0 °C
MgBr
HO
84%
O
N
O
OTBS
45  
3-((tert-Butyldimethylsilyloxy)methyl)-4-ethynyl-3a,4,5,6,7,7a-hexahydrobenzo[d]isoxazol-
4-ol (46). To a solution of the ketone 45 (0.511 g, 1.802 mmol, 1 equiv) in THF (18 mL) at 0 °C 
was added ethynylmagnesium bromide (14 mL of a 0.5 M soln in THF, 7 mmol, 4 equiv) over 
25 min via syringe pump.  The mixture stirred at 0 °C and reaction progress was monitored by 
TLC.  Complete consumption of the starting material was observed ~30 min after the addition 
was finished; the reaction was quenched by pouring the mixture into a flask containing sat     
NH4Cl solution.  The aqueous layer was extracted with Et2O (4×) and the combined organic 
layers were washed with brine, dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The residue was purified via column chromatography, using EtOAc/hexanes (1:6) as 
the eluent, to give pure propargyl alcohol 46 (0.470 g, 84%) as a colorless oil.  1H NMR (300 
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MHz, CDCl3): δ 4.67-4.61 (m, 1H), 4.62 (A of ABq, J = 11.7 Hz, 1H), 4.45 (B of ABq, J = 11.7 
Hz, 1H), 3.53 (d, J = 9.0 Hz, 1H), 2.48 (s, 1H), 1.97-1.71 (m, 4H), 1.61-1.50 (m, 1H), 0.93 (s, 
9H), 0.16 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 157.6, 87.2, 80.2, 71.6, 65.4, 58.6, 57.9, 36.6, 
25.8, 25.0, 18.2, 16.1, -5.5; IR (neat, NaCl): 3416, 3310, 2930, 2090, 1257, 1081, 838 cm-1; MS 
m/z (%): 309 (9), 294 (69), 252 (82), 105 (74), 74 (100); EI-HRMS calcd for C16H27NO3Si [M]+ 
m/z: 309.1760, found: 309.1762. 
N
O
OTBS
46
HO DCM, 0 °C
N
O
OTBS
47
AcO
Ac2O, TEA, DMAP
74%
 
3-((tert-Butyldimethylsilyloxy)methyl)-4-ethynyl-3a,4,5,6,7,7a-hexahydrobenzo[d]-isoxazol-
4-yl acetate (47). To a soln of the propargyl alcohol 46 (0.560 g, 1.81 mmol, 1 equiv) and 
DMAP (0.230 g, 1.88 mmol, 1 equiv) in DCM (18 mL) at 0 °C were added Ac2O (1.7 mL, 18.00 
mmol, 10 equiv) and TEA (2.5 mL, 17.94 mmol, 10 equiv).  The mixture stirred at 0 °C and 
reaction progress was monitored by TLC.  After approximately 12 h, the reaction was quenched 
by addition of saturated NaHCO3 soln and the aqueous layer was extracted with DCM (3×).  The 
combined organic layers were washed with brine, dried (MgSO4), filtered, and concentrated 
under reduced pressure.  The residue was purified by column chromatography, eluting with 
EtOAc/hexanes (1:6), to give pure propargyl acetate 47 (0.504 g, 74%) as a colorless oil.  1H 
NMR (300 MHz, CDCl3): δ 4.58 (A of ABq, J = 12.7 Hz, 1H), 4.52 (B of ABq, J = 12.7 Hz, 
1H), 4.54-4.50 (m, 1H), 3.58 (d, J = 8.4 Hz, 1H), 2.72-2.66 (m, 1H), 2.68 (s, 1H), 2.12-2.04 (m, 
1H), 2.03 (s, 3H), 1.87-1.57 (m, 5H), 0.91 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 168.7, 159.8, 82.8, 79.0, 74.9, 70.8, 58.7, 54.3, 32.4, 25.8, 24.2, 21.8, 18.2, 15.3, -5.2, 
-5.4; IR (neat, NaCl): 3250, 2931, 2100, 1748, 1221, 1076, 838 cm-1; MS m/z (%) 294 (85), 234 
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(100), 156 (20), 117 (41), 105 (24); EI-HRMS calcd for C17H26NO4Si [M]+ m/z: 336.1631, 
found: 336.1631. 
N
O
OTBS
47
AcO toluene, H2O
[(Ph3P)CuH]6
87%
N
O
OTBS
48
•
 
3-((tert-Butyldimethylsilyloxy)methyl)-4-vinylidene-3a,4,5,6,7,7a-
hexahydrobenzo[d]isoxazole (48). To a dark red suspension of [(Ph3P)CuH]682 (1.68 g, 0.86 
mmol, 0.50 equiv) in toluene (8.5 mL) was added a mixture of the propargyl acetate 47 (0.607 g, 
1.727 mmol, 1 equiv), toluene (17 mL) and water (0.08 mL, 4.44 mmol, 2.57 equiv) via cannula 
over 20 min.  The mixture gradually turned brown (i.e., appeared quenched) approximately 1 h 
after the addition.  The septum was removed from the flask and the contents stirred open to the 
air for 20 min before being diluted with Et2O and filtered through a plug of silica gel.  After 
concentration under reduced pressure, the filtrate was purified by column chromatography using 
gradient elution with hexanes/EtOAc (19:1, 9:1).  A second purification using 19:1 
hexanes/EtOAc was required to remove remaining PPh3.  Allene 48 (0.305 g, 87%) was obtained 
as a colorless oil.  1H NMR (300 MHz, CDCl3): δ 4.72-4.60 (m, 3H), 4.46 (A of ABq, J = 13.2 
Hz, 1H), 4.42 (B of ABq, J = 13.2 Hz, 1H), 3.86 (br d, J = 9.3 Hz, 1H), 2.17-2.12 (m, 2H), 1.79-
1.62 (m, 4H), 1.53-1.45 (m, 1H), 0.87 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δ 205.6, 160.2, 95.3, 79.7, 75.2, 58.0, 49.0, 27.2, 26.1, 25.7, 19.3, 18.1, -5.5, -5.6; IR 
(neat, NaCl): 2953, 2830, 1960, 1255, 1088, 839 cm-1; MS m/z (%): 278 (41), 239 (33), 238 (96), 
237 (73), 236 (100), 156 (13); EI-HRMS calcd for C15H24NO2Si [M]+ m/z: 278.1576, found: 
278.1576. 
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(4-Vinylidene-3a,4,5,6,7,7a-hexahydrobenzo[d]isoxazol-3-yl)methanol (49). To a soln of the 
TBS ether 48 (0.166 g, 0.565 mmol, 1 equiv) in THF (5.7 mL) at 0 °C was added TBAF (0.85 
mL of a 1.0 M soln in THF, 0.85 mmol, 1.5 equiv) dropwise.  Mixture stirred at 0 °C and the 
reaction progress was monitored by TLC.  Approximately 20 min after the addition was 
complete, the reaction was quenched by the addition of sat. NH4Cl soln.  The aqueous layer was 
extracted with Et2O (4×).  The combined organic layers were washed with brine, dried (MgSO4), 
filtered, and concentrated under reduced pressure.  The crude residue was purified via column 
chromatography, using EtOAc/hexanes (3:7), to give alcohol 49 (0.075 g, 75%) as a pale yellow 
oil.  1H NMR (300 MHz, CDCl3): δ 4.72-4.71 (m, 2H), 4.64 (dt, J = 9.1, 5.1 Hz, 1H), 4.42 (A of 
ABq, J = 14.7 Hz, 1H), 4.34 (B of ABq, J = 14.7 Hz, 1H), 3.84 (br d, J = 9.1 Hz, 1H), 3.25 (br s, 
1H), 2.20-2.10 (m, 2H), 1.78-1.58 (m, 3H), 1.53-1.40 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 
205.4, 161.0, 95.0, 79.7, 75.6, 57.6, 49.1, 27.1, 26.1, 19.4; IR (neat, NaCl): 3392, 2941, 1959, 
1610, 1442, 1037 cm-1.  
N
O
OH
49
•
TEA, DCM, -65 °C
(COCl)2, DMSO N
O
O
50
•75%
 
4-Vinylidene-3a,4,5,6,7,7a-hexahydrobenzo[d]isoxazole-3-carbaldehyde (50). To a soln of 
oxalyl chloride (0.08 mL, 0.932 mmol, 2.1 equiv) in DCM (3 mL) at –65 °C was added a soln of 
DMSO (0.14 mL, 1.971 mmol, 4.4 equiv) in DCM (1.5 mL) dropwise over 10 min.  The mixture 
stirred 10 min before a soln of the alcohol 49 (0.080 g, 0.446 mmol, 1 equiv) in DCM (1.5 mL) 
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was added dropwise over 10 min.  The mixture became cloudy while stirring for approximately 
20 min at –65 °C.  TEA was added dropwise over 5 min and the mixture was allowed to warm to 
room temperature over 30 min.  The reaction mixture was washed with sat NH4Cl soln and 
water.  The combined aqueous washings were back-extracted with DCM (3×).  The combined 
organic layers were washed with brine, dried (MgSO4), filtered, and concentrated under reduced 
pressure.  The crude residue was purified via column chromatography, eluting with 
hexanes/EtOAc (6:1), to give aldehyde 50 (0.059 g, 75%) as a colorless oil.  1H NMR (300 MHz, 
CDCl3): δ 9.90 (s, 1H), 4.75-4.64 (m, 2H), 3.94 (dt, J = 8.7, 3.6 Hz, 1H), 2.30-2.01 (m, 3H), 
1.88-1.77 (m, 1H), 1.71-1.60 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 204.9, 185.4, 162.2, 95.4, 
84.5, 76.9, 44.4, 26.9, 24.7, 19.4; IR (neat, NaCl): 2946, 2843, 1960, 1696, 1160 cm-1; MS m/z 
(%): 177 (65), 160 (82), 106 (87), 105 (100), 104 (70); EI-HRMS calcd for C10H11NO2 [M]+ m/z: 
177.0790, found: 177.0781. 
N
O
O•
Br
Zn, sat NH4Cl, THF
N
O
OH•
54-70%
5350  
1-(4-Vinylidene-3a,4,5,6,7,7a-hexahydrobenzo[d]isoxazol-3-yl)but-3-yn-1-ol (53). To a slurry 
of Zn dust (0.046 g, 0.701 mmol, 5 equiv) in THF (0.2 mL) at 0 °C, a soln of the aldehyde 50 
(0.025 g, 0.140 mmol, 1 equiv) in THF (0.2 mL) and propargyl bromide (0.04 mL of an 80 wt% 
soln in toluene, 0.359 mmol, 2.5 equiv) were added, followed by the addition of sat NH4Cl soln 
(0.16 mL) dropwise over 45 min.  The reaction mixture was allowed to slowly warm to room 
temperature and stirred overnight.  After approximately 20 hours, TLC indicated complete 
consumption of starting material and the reaction mixture was filtered through a pad of Celite.  
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The filtrate was washed with sat NH4Cl soln and brine, dried (Na2SO4), filtered, and 
concentrated under reduced pressure.  The residue was purified via column chromatography 
using hexanes/EtOAc (3:1) as the eluent.  The homopropargyl alcohol 53 (0.021 g, 70%) was 
achieved as a pale yellow crystalline solid and an approximate 3:1 mixture of diastereomers (1H 
NMR).  1H NMR (300 MHz, CDCl3): δ 4.78-4.75 (m, 3H), 4.68-4.66 (m, 1H), 4.00 (br d, J = 
9.3, 0.2 H),* 3.89 (br d, J = 9.0, 0.8 H),** 2.96 (br d, J = 5.7, 1H), 2.75 (A of ABqdd, J = 17.1, 
5.4, 2.7, 1H), 2.65 (B of ABqdd, J = 17.1, 5.7, 2.7, 1H), 2.26-2.13 (m, 2H), 2.08 (t, J = 2.7, 1H), 
1.86-1.48 (m, 4H); 13C NMR (75 MHz, CDCl3): δ 205.8, 161.1, 95.3, 80.6, 78.9, 75.8, 71.6, 
66.8, 49.8, 27.2, 26.3, 25.6, 19.5; IR (neat, NaCl): 3390, 3292, 2946, 2120, 1958, 1059.  (*Minor 
diastereomer; **major diastereomer.) 
N
O
O•
Br
2 equiv n-BuLi, TMEDA, 
then TMSCl
21%, 2:1 dr
N
O
OTMS•
5450
TMS
 
3-(4-(Trimethylsilyl)-1-(trimethylsilyloxy)but-3-ynyl)-4-vinylidene-3a,4,5,6,7,7a-
hexahydrobenzo[d]isoxazole (54). n-BuLi (0.5 mL of a 1.6 M soln in hexanes, 0.8 mmol, 4.2 
equiv) was added to a mixture of Et2O (0.7 mL) and hexanes (0.3 mL) at -78 °C.  TMEDA (30 
μL, 0.2 mmol, 1.05 equiv) was added dropwise followed by slow dropwise addition of propargyl 
bromide (45 μL of an 80 wt% soln in toluene, 0.5 mmol, 2.1 equiv).  A white precipitate 
developed upon stirring at –78 °C 20 min.  A soln of the aldehyde 50 (0.034 g, 0.192 mmol, 1 
equiv) in Et2O (0.25 mL) was added dropwise and the mixture continued to stir at –78 °C until 
complete consumption of starting material was observed by TLC.  The reaction was then 
quenched by rapid addition of TMSCl (0.10 mL, 0.79 mmol, 4 equiv).  The mixture was allowed 
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to slowly approach room temperature until no additional progress was observed by TLC, at 
which point the mixture was poured into an Erlenmeyer flask containing ~10 mL H2O.  The 
aqueous layer was extracted with Et2O (4×).  The combined organic portions were dried 
(Na2SO4), filtered, and concentrated under reduced pressure.  The residue was purified by 
column chromatography, using hexanes/EtOAc (9:1) as the eluent, to give allene-yne 54 (0.014 
g, 21%) as a 2:1 mixture of diastereomers (1H NMR).  1H NMR (300 MHz, CDCl3): δ 4.74-4.67 
(m, 4H), 3.98 (d, 9.9 Hz, 0.3H),* 3.92 (d, J = 9.6 Hz, 0.7H),** 2.78 (A of ABqd, J = 16.8, 5.7 
Hz, 1H), 2.65 (B of ABqd, J = 16.8, 7.8 Hz, 1H), 2.28-2.20 (m, 2H), 1.80-1.35 (m, 4H), 0.20 (s, 
9H), 0.15 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 206.1, 160.2, 103.2, 95.8, 86.8, 80.2, 75.3, 
67.4, 49.6, 27.0, 26.5, 26.4, 19.3, 0.3, 0.0; IR (neat, NaCl): cm-1; TOF-HRMS calcd for 
C19H31NO2Si2 [M+H]+ m/z: 362.1972, found: 362.1955.  (*Minor diastereomer; **major 
diastereomer.) 
N
O
OTMS
54
•
TMS
OTMS
O
N
O
30 mol% [Rh(CO)2Cl]2
CO, toluene, 60 °C
91%
TMS
59
 
Cyclopentenone 59. To a test tube containing the allene-yne 54 (0.013 g, 0.036 mmol) and a stir 
bar was added toluene (0.4 mL).  The test tube was evacuated and flushed with CO (3×).  
[Rh(CO)2Cl]2 (0.005 g, 0.012 mmol, 0.33 equiv) was added in one portion and the test tube was 
evacuated and flushed with CO (3×) before being placed under CO (1 atm) and immersed in a 60 
°C bath.  TLC analysis indicated near complete consumption of starting material after 3.5 h, at 
which point the reaction mixture was flushed through a plug of silica gel with hexanes/EtOAc 
(1:1) to remove the Rh catalyst.  The collected eluent was concentrated under reduced pressure 
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and the residue was purified via column chromatography using hexanes/EtOAc (3:1) as the 
eluent, giving the major diastereomer of cyclopentenone 59 (0.010 g, 73%) followed by the 
minor diastereomer (0.003 g, 21%).  Both were white crystalline solids. Major diastereomer: 1H 
NMR (300 MHz, CDCl3): δ 5.01 (t, J = 3.6 Hz, 1H), 4.55 (dt, J = 8.2, 3.0 Hz, 1H), 3.81 (br d, J 
= 8.2 Hz, 1H), 3.39 (dd, J = 14.4, 3.6 Hz, 1H), 2.95 (A of ABq, J = 20.4 Hz, 1H), 2.88 (B of 
ABq, J = 20.4, 1H), 2.85 (dd, J = 14.4, 3.6 Hz, 1H), 2.58-2.53 (m, 1H), 2.28-2.24 (m, 1H), 1.87-
1.67 (m, 4H), 0.28 (s, 9H), 0.20 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 208.2, 173.4, 162.7, 
135.8, 132.8, 80.4, 66.3, 49.3, 41.6, 37.3, 31.0, 25.1, 19.2, 0.2, 0.1; IR (neat, NaCl): 2950, 2880, 
1676, 1549, 1246, 839 cm-1; MS m/z (%): 389 (11), 374 (61), 147 (29), 75 (74), 73 (100); HR-
EIMS calcd for C20H31NO3Si [M]+ m/z: 389.1843, found: 389.1839.  Minor diastereomer: 1H 
NMR (300 MHz, CDCl3): δ 4.76 (dd, J = 10.8, 5.4 Hz, 1H), 4.55-4.53 (m, 1H), 3.92 (d, J = 6.9 
Hz, 1H), 3.35 (dd, J = 13.5, 5.4 Hz, 1H), 2.99-2.78 (m, 3H), 2.56-2.51 (m, 1H), 2.35-2.31 (m, 
1H), 2.04-1.69 (m, 4H), 0.29 (s, 9H), 0.21 (s, 9H).  
OH
OH
(S)-65
reflux O
P
O
Cl
(S)-66
toluene/THF, -40 °C → rt
77% O
P
O
N
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Ph
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N
Ph
Ph
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O,O’-(S)-(1,1’-Dinaphthyl-2,2’-diyl)-N,N’-di-(R,R)-1-phenylethylphosphoramidite (64).  In 
the glove box, a 25 mL schlenk flask was charged with (S)-BINOL (65, 1.063 g, 3.714 mmol, 1 
equiv) and PCl3 (4 mL, 46 mmol, 12 equiv).  The flask was removed from the glove box and the 
suspension was heated to reflux under Ar atmosphere.  After refluxing 16 h, the mixture had 
become a homogeneous solution.  After an additional 8 h, the excess PCl3 was removed under 
vacuum at 40 °C.  The foamy residue was dissolved in toluene (3 mL) and the solvent was 
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removed under vacuum.  This step was repeated two more times (2 × 3 mL toluene).  The residue 
remained under vacuum for 16 h after the final rinse.  In a separate flask, n-BuLi (2.6 mL of a 
1.6 M soln in hexanes, 4.2 mmol, 1.1 equiv) was added dropwise via syringe to a soln of bis((R)-
phenylethyl)amine (0.85 mL, 3.72 mmol, 1 equiv) in THF (13 mL) at -78 °C.  The fuschia-
colored soln was allowed to warm to -40 °C.  The phosphochloridite 66 was dissolved in toluene 
(20 mL) and the soln was added to the deprotonated amine 68 via cannula.  The amber-colored 
soln was allowed to warm from -40 °C to rt and stirred 16 h.  The resulting cloudy mixture was 
filtered through a pad of celite and the filtrate was concentrated under reduced pressure.  The 
residue was purified by column chromatography using hexanes/EtOAc (14:1) as the eluent to 
give pure phosphoramidite (S,R,R)-64 (1.770 g, 77%) as a white foamy solid.  The 1H NMR 
spectrum is in agreement with published values.96 
O
MeO OMe
1 mol% Cu(OTf)2
2.4 mol% (S,R,R)-64
toluene, -25 °C
50%
62
O
MeO OMe
60
*
 
4,4-Dimethoxy-5-methyl-2-cyclohexenone (60).  To a two-neck roundbottom flask fitted with a 
thermometer adapter and containing a suspension of Cu(OTf)2 (0.059 g, 0.162 mmol, 0.010 
equiv) in toluene (25 mL) was added a soln of the phosphoramidite ligand (S,R,R)-64 (0.201 g, 
0.373 mmol, 0.024 equiv) in toluene (6 mL).  The pale orange mixture stirred 1 h before being 
cooled to -25 °C in a cryocool bath.  The cyclohexadienone 6292 (2.390 g, 15.51 mmol, 1 equiv) 
was added.  Me2Zn (21 mL of a 1.2 M soln in toluene, 25 mmol, 1.6 equiv) was added so that the 
internal temperature ≤-20 °C.  The bright yellow reaction mixture stirred at -25 °C and the 
reaction progress was monitored every 30 min by TLC.  After 4 h, the slightly less polar 
diaddition product was visible above the monoaddition product spot on the TLC plate.  The 
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reaction was quenched by pouring the mixture into an Erlenmeyer flask containing rapidly 
stirring 1.5 M NaOH.  The aqueous layer was extracted with Et2O (3×).  The combined organic 
layers were washed with 1.5 N NaOH and brine, dried (Na2SO4), filtered and carefully 
concentrated under reduced pressure to remove most of the Et2O.  The remaining 3:1 mixture (by 
1H NMR) of enone 60 and unreacted sm in toluene was applied to a silica gel column and eluted 
with pentane/Et2O (3:1 to 0:1) to separate the toluene from the product mixture.  Fractions 
containing the product were combined and carefully concentrated under reduced pressure.  The 
residue was purified by column chromatography, eluting with pentane/Et2O (3:1) to give pure 
cyclohexenone 60 (1.321 g, 50%) as a colorless oil.  The 1H NMR spectrum is in agreement with 
literature values.95 
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    H2O, NaOH, H2O2
28
OH
2. TBSCl, DMAP, TEA
3. Montmorillonite-K10
TBSO
O21%, 3 steps
74%
 
4-(1-(tert-Butyldimethylsilyloxy)propan-2-yl)-4-hydroxy-6-methyl-2-cyclohexenone (28).  
To the enone 60 (0.557 g, 3.28 mmol, 1 equiv) in THF (16 mL) at 0 °C was added 
isopropenylmagnesium bromide (20 mL of a 0.5 M soln in THF, 10 mmol, 3 equiv) via syringe 
pump over 20 min.  The reaction was monitored by TLC and quenched by pouring the reaction 
mixture into a flask containing saturated aqueous NH4Cl.  The aqueous layer was extracted with 
Et2O (4×).  The combined organic portions were washed with brine, dried (MgSO4), filtered, and 
concentrated under reduced pressure.  The crude residue was flushed through a plug of pretreated 
(TEA) silica gel with hexanes/EtOAc (4:1) to remove major impurities.  Tertiary alcohol 61 
(0.514 g, 74%) was obtained as an amber oil.  1H NMR (300 MHz, CDCl3): δ 5.80 (A of ABq, J 
= 10.2 Hz, 1H), 5.74 (B of ABq, J = 10.2 Hz, 1H), 5.02 (s, 1H), 4.88 (quintet, J = 1.5 Hz, 1H), 
 46 
3.28 (s, 3H), 3.22 (s, 3H), 2.18-2.12 (m, 2H), 1.77 (s, 3H), 1.68 (dd, J = 15.6, 6.6 Hz, 1H), 1.05 
(d, J = 6.9 Hz, 3H). 
To a soln of the olefin 61 (0.271 g, 1.276 mmol, 1 equiv) in THF (2 mL) was added 
BH3·DMS (0.64 mL of a 2 M soln in THF, 1.28 mmol, 1 equiv) dropwise via syringe.  The 
reaction was monitored by 1H NMR analysis of aliquots.  The reaction stirred 16 h, at which 
point the flask was placed in an ambient temperature water bath and H2O (0.11 mL, 6.1 mmol, 5 
equiv) was added followed by dropwise addition of NaOH (5 mL of a 3 M aqueous soln, 15 
mmol, 12 equiv) and H2O2 (2.2 mL of a 33 wt% aqueous soln, 23.5 mmol, 18 equiv).  The 
mixture stirred 3 h and was diluted with Et2O.  The aqueous layer was extracted with Et2O (4×).  
The combined organic portions were washed with brine, dried (Na2SO4), decanted, and 
concentrated under reduced pressure to give the crude primary alcohol (0.207 g, 71%).   
To a soln of DMAP (11 mg, 0.09 mmol, 0.1 equiv) and the primary alcohol (0.207 g, 
0.900 mmol, 1 equiv) in DCM (1 mL) was added TEA (0.31 mL, 2.22 mmol, 2.5 equiv) 
followed by dropwise addition of a soln of TBSCl (0.163 g, 1.08 mmol, 1.2 equiv) in DCM (0.5 
mL).  Reaction progress was monitored by TLC.  After 2 h, the mixture was diluted in H2O and 
the aqueous layer was extracted with DCM (3×).  The combined organic layers were washed 
with brine, dried (Na2SO4), decanted, and concentrated under reduced pressure, giving the crude 
silyl ether (0.310 g, 84%). 
To a soln of the ketal (0.259 g, 0.752 mmol) in DCM (15 mL) was added 
Montmorillonite K10 clay (0.378 g). Reaction progress was monitored by TLC.  After 10 min, 
additional clay was added (0.376 g).  When no starting material was observable by TLC, the 
reaction mixture was filtered through a pad of celite and the filtrate was concentrated under 
reduced pressure.  The crude residue, containing a 2:1 mix of diastereomers of 28 by 1H NMR, 
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was purified by column chromatography using 4:1 hexanes/EtOAc as the eluent to give the 
desired enone 28 (0.082 g, 36% from 57).  Partial separation of the diastereomers was achieved 
during column chromatography.  Major diastereomer: 1H NMR (300 MHz, CDCl3): δ 6.87 (dd, J 
= 10.3, 2.1 Hz, 1H), 5.92 (d, J = 10.3 Hz, 1H), 4.43 (s, 1H), 4.07 (dd, J = 10.5, 3.3 Hz, 1H), 3.68 
(dd, J = 10.5, 4.5 Hz, 1H), 2.48-2.36 (m, 2H), 2.08-1.94 (m, 2H), 1.17 (d, J = 6.3 Hz, 3H), 1.14 
(d, J = 6.9 Hz, 3H), 0.93 (s, 9H), 0.13 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 201.2, 154.7, 
127.9, 73.6, 66.9, 43.7, 40.2, 38.8, 18.0, 15.8, 12.7, -5.7, -5.8; IR (neat, NaCl): 3463, 2931, 2858, 
1684, 1462, 1377, 1073, 836 cm-1; MS m/z (%): 321 (12), 281 (16), 251 (80), 191 (13), 121 (29); 
TOF-HRMS calcd for C16H30O3NaSi [M + Na]+ m/z: 321.1862, found: 321.1858; Minor 
diastereomer: 1H NMR (300 MHz, CDCl3): δ 6.96 (dd, J = 10.2, 2.1 Hz, 1H), 5.92 (d, J = 10.2 
Hz, 1H), 4.39 (s, 1H), 4.05 (dd, J = 10.2, 3.0 Hz, 1H), 3.69 (dd, J = 10.2, 2.7 Hz, 1H), 2.39 (dqd, 
J = 13.5, 6.6, 4.7 Hz, 1H), 2.27 (ddd, J = 13.5, 4.7, 2.1 Hz, 1H), 1.99 (qt, J = 7.2, 3.0 Hz, 1H), 
1.76 (t, J = 13.5 Hz, 1H), 1.19 (d, J = 7.2 Hz, 3H), 1.18 (d, J = 6.6 Hz, 3H), 0.94 (s, 9 H), 0.13 (s, 
3H), 0.12 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 201.3, 156.3, 127.3, 73.8, 67.1, 41.2, 39.1, 
38.4, 25.8, 18.0, 15.7, 12.6, -5.7, -5.8. 
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